Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Phase I Combination Ixabepilone + Cisplatin

NCT00832117

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • The Cancer Institute Of New Jersey New Brunswick, New Jersey, United States
  • Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
  • Local Institution Lucca, Italy
View Trial Details
Completed

Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer

NCT00553254

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non Small Cell Lung, +8 more
Locations
  • Seoul National University Hospital, Department of Internal Medicine Seoul, South Korea
  • Severance Hospital, Yonsei University College of Medicine, Yonsei Cancer Center Seoul, South Korea
  • Samsung Medical Center, Department of Medicine Seoul, South Korea
View Trial Details
Completed

Single Arm on the Tolerability of Weekly Nab-paclitaxel

NCT01702844

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Rex Healthcare Raleigh, North Carolina, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients

NCT02879760

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Moncton Hospital Moncton, New Brunswick, Canada
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • Kingston General Hospital Kingston, Ontario, Canada
View Trial Details
Completed

A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC

NCT02451930

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists St. Petersburg, Florida, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France
View all 16 locations
View Trial Details

Related conditions